261 related articles for article (PubMed ID: 16166567)
1. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension.
Murata T; Kinoshita K; Hori M; Kuwahara M; Tsubone H; Karaki H; Ozaki H
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2335-42. PubMed ID: 16166567
[TBL] [Abstract][Full Text] [Related]
2. Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension.
Murata T; Sato K; Hori M; Ozaki H; Karaki H
J Biol Chem; 2002 Nov; 277(46):44085-92. PubMed ID: 12185080
[TBL] [Abstract][Full Text] [Related]
3. L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats.
Ou ZJ; Wei W; Huang DD; Luo W; Luo D; Wang ZP; Zhang X; Ou JS
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1131-9. PubMed ID: 20215577
[TBL] [Abstract][Full Text] [Related]
4. Κ-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension.
Wu Q; Wang HY; Li J; Zhou P; Wang QL; Zhao L; Fan R; Wang YM; Xu XZ; Yi DH; Yu SQ; Pei JM
PLoS One; 2013; 8(5):e60850. PubMed ID: 23667430
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.
Matsuda N; Hayashi Y; Takahashi Y; Hattori Y
J Pharmacol Exp Ther; 2006 Dec; 319(3):1348-54. PubMed ID: 17003232
[TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats.
Nishimatsu H; Suzuki E; Satonaka H; Takeda R; Omata M; Fujita T; Nagai R; Kitamura T; Hirata Y
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1770-6. PubMed ID: 15550522
[TBL] [Abstract][Full Text] [Related]
7. Buffered l-ascorbic acid, alone or bound to KMUP-1 or sildenafil, reduces vascular endothelium growth factor and restores endothelium nitric oxide synthase in hypoxic pulmonary artery.
Wu JR; Kao LP; Wu BN; Dai ZK; Wang YY; Chai CY; Chen IJ
Kaohsiung J Med Sci; 2015 May; 31(5):241-54. PubMed ID: 25910559
[TBL] [Abstract][Full Text] [Related]
8. Role of G(i/o)-Src kinase-PI3K/Akt pathway and caveolin-1 in β₂-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery.
Banquet S; Delannoy E; Agouni A; Dessy C; Lacomme S; Hubert F; Richard V; Muller B; Leblais V
Cell Signal; 2011 Jul; 23(7):1136-43. PubMed ID: 21385608
[TBL] [Abstract][Full Text] [Related]
9. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
[TBL] [Abstract][Full Text] [Related]
11. Waon therapy attenuates cardiac hypertrophy and promotes myocardial capillary growth in hypertensive rats: a comparative study with fluvastatin.
Ihori H; Nozawa T; Sobajima M; Shida T; Fukui Y; Fujii N; Inoue H
Heart Vessels; 2016 Aug; 31(8):1361-9. PubMed ID: 26686369
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
Brouet A; Sonveaux P; Dessy C; Moniotte S; Balligand JL; Feron O
Circ Res; 2001 Nov; 89(10):866-73. PubMed ID: 11701613
[TBL] [Abstract][Full Text] [Related]
13. HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.
Suh JW; Choi DJ; Chang HJ; Cho YS; Youn TJ; Chae IH; Kim KI; Kim CH; Kim HS; Oh BH; Park YB
J Korean Med Sci; 2010 Jan; 25(1):16-23. PubMed ID: 20052342
[TBL] [Abstract][Full Text] [Related]
14. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
[TBL] [Abstract][Full Text] [Related]
15. Tsantan Sumtang, a traditional Tibetan medicine, protects pulmonary vascular endothelial function of hypoxia-induced pulmonary hypertension rats through AKT/eNOS signaling pathway.
Li N; Su S; Xie X; Yang Z; Li Z; Lu D
J Ethnopharmacol; 2024 Feb; 320():117436. PubMed ID: 37979813
[TBL] [Abstract][Full Text] [Related]
16. Vasculoprotective effect of U50,488H in rats exposed to chronic hypoxia: role of Akt-stimulated NO production.
Li J; Shi QX; Fan R; Zhang LJ; Zhang SM; Guo HT; Wang YM; Kaye AJ; Kaye AD; Bueno FR; Xu XZ; Yu SQ; Yi DH; Pei JM
J Appl Physiol (1985); 2013 Jan; 114(2):238-44. PubMed ID: 23139366
[TBL] [Abstract][Full Text] [Related]
17. Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension.
Matsuo S; Saiki Y; Adachi O; Kawamoto S; Fukushige S; Horii A; Saiki Y
J Thorac Cardiovasc Surg; 2015 Mar; 149(3):902-9. PubMed ID: 25454916
[TBL] [Abstract][Full Text] [Related]
18. Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium.
Ozaki M; Kawashima S; Yamashita T; Ohashi Y; Rikitake Y; Inoue N; Hirata KI; Hayashi Y; Itoh H; Yokoyama M
Hypertension; 2001 Feb; 37(2):322-7. PubMed ID: 11230292
[TBL] [Abstract][Full Text] [Related]
19. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
[TBL] [Abstract][Full Text] [Related]
20. Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension.
Chandrasekar I; Eis A; Konduri GG
Pediatr Res; 2008 Jan; 63(1):67-72. PubMed ID: 18043518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
